Literature DB >> 12636219

Tissue engineering.

Michael J Miller1, Charles W Patrick.   

Abstract

Tissue engineering will potentially change the practice of plastic surgery more than any other clinical specialty. It is an interdisciplinary field that promises new methods of tissue repair. There has been more than $3.5 billion invested in this field since 1990. Relevant areas of progress include advanced computing, biomaterials, cell technology, growth factor fabrication and delivery, and gene manipulation. Beneficial clinical techniques will emerge from continued investigation in each of these areas. Techniques that are developed must be scaled up to industry with products cleared by regulatory agencies and acceptable to clinicians and patients. A goal of tissue engineering is to change clinical practice, yielding improved patient outcomes and lower costs of care.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636219     DOI: 10.1016/s0094-1298(02)00071-8

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  7 in total

1.  Adipose tissue engineering from human adult stem cells: clinical implications in plastic and reconstructive surgery.

Authors:  Michael S Stosich; Jeremy J Mao
Journal:  Plast Reconstr Surg       Date:  2007-01       Impact factor: 4.730

2.  A novel strategy for engineering vascularized grafts in vitro.

Authors:  Jin-Chun Liu
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

Review 3.  Bioengineering strategies to generate vascularized soft tissue grafts with sustained shape.

Authors:  Michael S Stosich; Eduardo K Moioli; June K Wu; Chang Hun Lee; Christine Rohde; Azizeh Mitra Yoursef; Jeffrey Ascherman; Robert Diraddo; Nicholas W Marion; Jeremy J Mao
Journal:  Methods       Date:  2008-10-24       Impact factor: 3.608

Review 4.  Surgical reconstruction in patients with cancer of the head and neck.

Authors:  Emre Vural
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

5.  Analysis of intellectual properties on animal-derived regenerative, implantable medical devices.

Authors:  Hongman Wang; Chunying Li
Journal:  Regen Biomater       Date:  2015-12-18

6.  Polycaprolactone nanofibrous mesh reduces foreign body reaction and induces adipose flap expansion in tissue engineering chamber.

Authors:  Lin Luo; Yunfan He; Qiang Chang; Gan Xie; Weiqing Zhan; Xuecen Wang; Tao Zhou; Malcolm Xing; Feng Lu
Journal:  Int J Nanomedicine       Date:  2016-12-05

Review 7.  Regulatory and microbiological safety issues surrounding cell and tissue-engineering products.

Authors:  Daniel N Galbraith
Journal:  Biotechnol Appl Biochem       Date:  2004-08       Impact factor: 2.431

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.